AFP and neoplasm: Although no clear trend for AFP or L3% was observed during the course of either treatment, the increment ratio of DCP during the course of treatment was significantly larger in the monotherapy group, suggesting a better tumor control capability from the combination therapy (p < 0.0001, Fig. 2b).